145 related articles for article (PubMed ID: 10369359)
21. Malignancy of brain tumors evaluated by proton magnetic resonance spectroscopy (1H-MRS) in vitro.
Czernicki Z; Horsztyński D; Jankowski W; Grieb P; Walecki J
Acta Neurochir Suppl; 2000; 76():17-20. PubMed ID: 11449999
[TBL] [Abstract][Full Text] [Related]
22. Robot-assisted stereotactic biopsy of pediatric brainstem and thalamic lesions.
Gupta M; Chan TM; Santiago-Dieppa DR; Yekula A; Sanchez CE; Elster JD; Crawford JR; Levy ML; Gonda DD
J Neurosurg Pediatr; 2020 Dec; 27(3):317-324. PubMed ID: 33361479
[TBL] [Abstract][Full Text] [Related]
23. Analysis of metabolic indices in regions of abnormal perfusion in patients with high-grade glioma.
Lupo JM; Cha S; Chang SM; Nelson SJ
AJNR Am J Neuroradiol; 2007 Sep; 28(8):1455-61. PubMed ID: 17846190
[TBL] [Abstract][Full Text] [Related]
24. Non-invasive characterization of brain tumor by in-vivo proton magnetic resonance spectroscopy.
Harada M; Tanouchi M; Nishitani H; Miyoshi H; Bandou K; Kannuki S
Jpn J Cancer Res; 1995 Mar; 86(3):329-32. PubMed ID: 7744704
[TBL] [Abstract][Full Text] [Related]
25. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
26. Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings.
Chiang IC; Kuo YT; Lu CY; Yeung KW; Lin WC; Sheu FO; Liu GC
Neuroradiology; 2004 Aug; 46(8):619-27. PubMed ID: 15243726
[TBL] [Abstract][Full Text] [Related]
27. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
Floeth FW; Pauleit D; Wittsack HJ; Langen KJ; Reifenberger G; Hamacher K; Messing-Jünger M; Zilles K; Weber F; Stummer W; Steiger HJ; Woebker G; Müller HW; Coenen H; Sabel M
J Neurosurg; 2005 Feb; 102(2):318-27. PubMed ID: 15739561
[TBL] [Abstract][Full Text] [Related]
28. Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma.
Broniscer A; Gajjar A; Bhargava R; Langston JW; Heideman R; Jones D; Kun LE; Taylor J
Neurosurgery; 1997 Feb; 40(2):331-7; discussion 337-8. PubMed ID: 9007866
[TBL] [Abstract][Full Text] [Related]
29. Combined 1H-MR imaging and localized 31P-spectroscopy of intracranial tumors in 43 patients.
Heindel W; Bunke J; Glathe S; Steinbrich W; Mollevanger L
J Comput Assist Tomogr; 1988; 12(6):907-16. PubMed ID: 3183124
[TBL] [Abstract][Full Text] [Related]
30. Primary and metastatic intraaxial brain tumors: prospective comparison of multivoxel 2D chemical-shift imaging (CSI) proton MR spectroscopy, perfusion MRI, and histopathological findings in a group of 159 patients.
Bendini M; Marton E; Feletti A; Rossi S; Curtolo S; Inches I; Ronzon M; Longatti P; Di Paola F
Acta Neurochir (Wien); 2011 Feb; 153(2):403-12. PubMed ID: 21165751
[TBL] [Abstract][Full Text] [Related]
31. Proton magnetic resonance spectroscopy-guided biopsy for cerebral glial tumors.
Chen CY; Lirng JF; Chan WP; Fang CL
J Formos Med Assoc; 2004 Jun; 103(6):448-58. PubMed ID: 15278190
[TBL] [Abstract][Full Text] [Related]
32. [Differential diagnosis of bilateral thalamic lesions].
Linn J; Hoffmann LA; Danek A; Brückmann H
Rofo; 2007 Mar; 179(3):234-45. PubMed ID: 17325992
[TBL] [Abstract][Full Text] [Related]
33. Assessment of malignancy in gliomas by 3T 1H MR spectroscopy .
Jeun SS; Kim MC; Kim BS; Lee JM; Chung ST; Oh CH; Lee SY; Choe BY
Clin Imaging; 2005; 29(1):10-5. PubMed ID: 15859012
[TBL] [Abstract][Full Text] [Related]
34. Metabolic response of glioblastoma to adoptive immunotherapy: detection by phosphorus MR spectroscopy.
Ross BD; Tropp J; Derby KA; Sugiura S; Hawryszko C; Jacques DB; Ingram M
J Comput Assist Tomogr; 1989; 13(2):189-93. PubMed ID: 2925904
[TBL] [Abstract][Full Text] [Related]
35. Proton magnetic resonance spectroscopy of astrocytic tumors: an in vitro study.
Kinoshita Y; Kajiwara H; Yokota A; Koga Y
Neurol Med Chir (Tokyo); 1993 Jun; 33(6):350-9. PubMed ID: 7689180
[TBL] [Abstract][Full Text] [Related]
36. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
37. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation.
Toyooka M; Kimura H; Uematsu H; Kawamura Y; Takeuchi H; Itoh H
Clin Imaging; 2008; 32(4):251-8. PubMed ID: 18603178
[TBL] [Abstract][Full Text] [Related]
38. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy.
Shimizu H; Kumabe T; Tominaga T; Kayama T; Hara K; Ono Y; Sato K; Arai N; Fujiwara S; Yoshimoto T
AJNR Am J Neuroradiol; 1996 Apr; 17(4):737-47. PubMed ID: 8730195
[TBL] [Abstract][Full Text] [Related]
39. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
Alger JR; Frank JA; Bizzi A; Fulham MJ; DeSouza BX; Duhaney MO; Inscoe SW; Black JL; van Zijl PC; Moonen CT
Radiology; 1990 Dec; 177(3):633-41. PubMed ID: 2243962
[TBL] [Abstract][Full Text] [Related]
40. Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy.
Bradac O; Vrana J; Jiru F; Kramar F; Netuka D; Hrabal P; Horinek D; de Lacy P; Benes V
Br J Neurosurg; 2014 Oct; 28(5):631-6. PubMed ID: 24377726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
